Precision Optics Expands Facilities to Meet Growing Backlog
GARDNER, Mass. and LITTLETON, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced it has made the strategic decision to move its corporate offices, including executive leadership, product development engineering, program management, human resources, business development and accounting, from Gardner, MA to Littleton, MA. The move allows for the consolidation of dedicated production capabilities at POC's existing facilities in Gardner to meet the Company's growing production backlog, which stood at an all-time high at the end of the most recent quarter. This new facility in Littleton, along with a new facility in South Portland, Maine, also allows POC access to a broader engineering talent pool to execute on the Company's ongoing product development pipeline.
Joe Forkey, CEO of Precision Optics, commented. 'As our business has grown, it has become evident that we need to expand our production facilities in a cost-efficient manner to meet our growing backlog; and we need to access the best possible engineering talent that Massachusetts and Maine have to offer. Today's announcement accomplishes both of these objectives.'
Effective August 1st, 2025, we expect the Company's new corporate headquarters will be 550 King St, Building A, Suite 100, Littleton, MA.
About Precision Optics CorporationFounded in 1982, Precision Optics is a vertically integrated optics company primarily focused on leveraging its proprietary micro-optics, 3D imaging and digital imaging technologies to the healthcare and defense/aerospace industries by providing services ranging from new product concept through mass manufacture. Utilizing its leading-edge in-house design, prototype, regulatory and fabrication capabilities as well as its Ross Optical division's high volume world-wide sourcing, inspecting and production resources, the Company is able to design and manufacture next-generation product solutions to the most challenging customer requirements. Within healthcare, Precision Optics enables next generation medical device companies around the world to meet the increasing demands of the surgical community who require more enhanced and smaller imaging systems for minimally invasive surgery as well as 3D endoscopy systems to support the rapid proliferation of surgical robotic systems. In addition to these next generation applications, Precision Optics has supplied top tier medical device companies a wide variety of optical products for decades, including complex endocouplers and specialized endoscopes. The Company is also leveraging its technical proficiency in micro-optics to enable leading edge defense/aerospace applications which require the highest quality standards and the optimization of size, weight and power. For more information, please visit www.poci.com.
About Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of U.S. federal securities laws. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of the Company in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on the Company as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting the Company will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the demand for the Company's products, global supply chains and economic activity in general and other risks and uncertainties identified in the Company's filings with the SEC. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.
Company Contact: PRECISION OPTICS CORPORATION22 East BroadwayGardner, Massachusetts 01440-3338Telephone: 978-630-1800
Investor Contact:LYTHAM PARTNERS, LLCRobert BlumTelephone: 602-889-9700poci@lythampartners.comSign in to access your portfolio
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
National CineMedia (NASDAQ:NCMI) investors are sitting on a loss of 79% if they invested five years ago
Some stocks are best avoided. We really hate to see fellow investors lose their hard-earned money. Anyone who held National CineMedia, Inc. (NASDAQ:NCMI) for five years would be nursing their metaphorical wounds since the share price dropped 83% in that time. Furthermore, it's down 11% in about a quarter. That's not much fun for holders. While a drop like that is definitely a body blow, money isn't as important as health and happiness. Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Because National CineMedia made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size. Over five years, National CineMedia grew its revenue at 1.6% per year. That's not a very high growth rate considering it doesn't make profits. Nonetheless, it's fair to say the rapidly declining share price (down 13%, compound, over five years) suggests the market is very disappointed with this level of growth. We'd be pretty cautious about this one, although the sell-off may be too severe. We'd recommend focussing any further research on the likelihood of profitability in the foreseeable future, given the muted revenue growth. You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image). You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic. It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. As it happens, National CineMedia's TSR for the last 5 years was -79%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence! We're pleased to report that National CineMedia shareholders have received a total shareholder return of 19% over one year. That's including the dividend. There's no doubt those recent returns are much better than the TSR loss of 12% per year over five years. This makes us a little wary, but the business might have turned around its fortunes. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with National CineMedia , and understanding them should be part of your investment process. But note: National CineMedia may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. — Investing narratives with Fair Values Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges By Robbo – Community Contributor Fair Value Estimated: A$2.42 · 0.1% Overvalued Vossloh rides a €500 billion wave to boost growth and earnings in the next decade By Chris1 – Community Contributor Fair Value Estimated: €78.41 · 0.1% Overvalued Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth By Unike – Community Contributor Fair Value Estimated: $325.55 · 0.6% Undervalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
York Water (NASDAQ:YORW) shareholders have endured a 26% loss from investing in the stock five years ago
The main aim of stock picking is to find the market-beating stocks. But every investor is virtually certain to have both over-performing and under-performing stocks. So we wouldn't blame long term The York Water Company (NASDAQ:YORW) shareholders for doubting their decision to hold, with the stock down 33% over a half decade. Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. During the unfortunate half decade during which the share price slipped, York Water actually saw its earnings per share (EPS) improve by 2.6% per year. Given the share price reaction, one might suspect that EPS is not a good guide to the business performance during the period (perhaps due to a one-off loss or gain). Alternatively, growth expectations may have been unreasonable in the past. By glancing at these numbers, we'd posit that the the market had expectations of much higher growth, five years ago. Having said that, we might get a better idea of what's going on with the stock by looking at other metrics. Revenue is actually up 8.6% over the time period. A more detailed examination of the revenue and earnings may or may not explain why the share price languishes; there could be an opportunity. The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image). It's probably worth noting that the CEO is paid less than the median at similar sized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. So it makes a lot of sense to check out what analysts think York Water will earn in the future (free profit forecasts). When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of York Water, it has a TSR of -26% for the last 5 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments! Investors in York Water had a tough year, with a total loss of 9.3% (including dividends), against a market gain of about 12%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 5% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Take risks, for example - York Water has 2 warning signs (and 1 which is significant) we think you should know about. If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. — Investing narratives with Fair Values Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges By Robbo – Community Contributor Fair Value Estimated: A$2.42 · 0.1% Overvalued Vossloh rides a €500 billion wave to boost growth and earnings in the next decade By Chris1 – Community Contributor Fair Value Estimated: €78.41 · 0.1% Overvalued Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth By Unike – Community Contributor Fair Value Estimated: $325.55 · 0.6% Undervalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
My 3 Favorite Stocks to Buy Right Now
Roku is a long-term growth play with recent volatility and a promising ad partnership with Amazon. Costco continues to deliver market-beating returns, justifying its premium price tag. Target is a risky turnaround story, priced for pessimism but showing signs of a strategic comeback. 10 stocks we like better than Roku › The stock market has been less predictable than usual lately. As I'm writing this on June 20, the S&P 500 (SNPINDEX: ^GSPC) index is up only 1.5% year to date. But this mellow return included a deep dip in April, so the index has gained 24% from the bottom of its 52-week low. So, things are extra volatile this year, and I understand if you'd rather keep some cash on hand right now. But even now, a few stocks can inspire me to put my extra cash to work. Read on to see why my hand hovers over the "buy" button for Roku (NASDAQ: ROKU), Costco (NASDAQ: COST), and Target (NYSE: TGT) in June 2025. Media-streaming technology veteran Roku has had quite a ride lately. Its stock price shot up by 50% over the past year but has taken a slight detour more recently, dropping 3% in the last six months. The growth story is still alive and well, with excitement over new deals, such as the recent Amazon (NASDAQ: AMZN) ad partnership, keeping optimism afloat. However, the company still isn't showing a profit, so valuation ratios based on profitability don't make any sense. Instead, you can look at Roku's price-to-sales (P/S) ratio, which sits at a reasonable 2.8. That metric floated in double-digit territory four years ago. For now, Roku is acting a bit like the kid in class who has tons of potential but hasn't quite turned in the homework -- yet. The platform is growing, and recent partnerships could be a game changer, but the market wants to see proof that all these moves will translate to real, scalable profits. That's why Roku's stock looks cheap in this period of growth-focused operations and limited profits. If you're in it for the long haul and don't mind a few twists and turns, Roku still looks like a compelling candidate for a growth-focused portfolio. It's one of the few stocks I don't mind buying right now since its short-term price moves tend to be unpredictable anyway. This is a long-term growth idea. Wholesale warehouse retailer Costco is a different story. The stock has been soaring for years, lifting the P/S ratio to a lofty 1.6. That would be low in the high-growth media-streaming market, but Costco's valuation looks luxurious next to other large-scale retailers. But the stock is rising for good reasons. The company has more cash and less debt than sector giant Walmart (NYSE: WMT). Trailing sales are up 61% over the last five years, while Walmart's sales increased by only 26%. Costco's return on invested capital is 26%, nearly twice that of Walmart's 14% reading. Long story short, Costco runs a superior business, and its stock deserves a price premium. This stock looked expensive five years ago, with a 5-year price gain of 114% at the time. By comparison, the S&P rose 47%, and Walmart gained 65% over the same time span. But if you cashed in your Costco gains or sat on your hands in 2020, you've missed out on a market-beating 227% return in the last 5 years: Costco's stock isn't cheap, but you get what you pay for -- a world-class retailer with a history of great shareholder returns. Last but not least, fellow big-box retailer Target tells another compelling story. Target's stock is down 21% in 5 years, and the P/S ratio stands at a skimpy 0.4. If investors are paying extra for Costco's incredible performance, they're stuffing Target shares in Wall Street's bargain bin. This is a turnaround story, not a march to ever greater heights. Turnarounds are risky, but this one should have a happy ending. The company is no longer competing against Walmart and Costco on lower prices, but is refocusing on the affordable-luxury status it once held. The new strategy leans on the nearly forgotten "Tar-zhay" branding. "In a world where shopping has become less inspiring, consumers expect us to be the place they can recapture the joy of retail," CEO Brian Cornell said in the fourth-quarter 2024 earnings call. "Our guests are looking for Tar-zhay. Consumers coined that term decades ago to define how we elevate the everything, every day to something special, how we add unexpected fun into shopping that would be otherwise routine." So, Target is betting the barn on a better shopping experience. The stores need to feel friendlier than Costco's or Walmart's low-cost emporiums. Nobody likes an empty shelf, so popular items must always be in stock -- even if it costs more to run a more complete supply chain. And the Target Circle loyalty program can't be all about discounts, which is why it also offers personalized product recommendations and extended product returns. Target's stock is priced for absolute disaster, but I see good things happening in the turnaround effort. It's a risky bet, but one worth making in the summer of 2025. Before you buy stock in Roku, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Roku wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Anders Bylund has positions in Amazon, Roku, and Walmart. The Motley Fool has positions in and recommends Amazon, Costco Wholesale, Roku, Target, and Walmart. The Motley Fool has a disclosure policy. My 3 Favorite Stocks to Buy Right Now was originally published by The Motley Fool
